Arteris insider Bayview Legacy sells 100,000 shares

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open‑market sales totaling 100,000 shares of common stock on August 3–4, 2026.

Rhea-AI Filing Summary

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open‑market sales totaling 100,000 shares of common stock on August 3–4, 2026. The five indirect transactions, executed under a Rule 10b5‑1 trading plan adopted on December 12, 2025, used weighted‑average pricing, with underlying trade ranges from $28.17 to $32.48 per share. K. Charles Janac, Bayview’s manager, is deemed to have voting and dispositive power over these shares and has separately reported his beneficial ownership.

Insider Trade Summary 10b5-1

Net Seller: 100,000 shares

Net Sell 5 txns

Insider Bayview Legacy, LLC

Role 10% Owner

Sold 100,000 shs ($3.05M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F7	23,506	$31.9217	$750K
Sale	Common Stock F1, F2, F8	2,600	$32.4149	$84K
Sale	Common Stock F1, F2, F3, F4	6,321	$28.7865	$182K
Sale	Common Stock F1, F2, F5	42,415	$29.9906	$1.27M
Sale	Common Stock F1, F2, F6	25,158	$30.3132	$763K

Holdings After Transaction: Common Stock — 8,329,071 shares (Indirect, See Footnote)

Footnotes (8)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.
2. F2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
3. F3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.15 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
5. F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.19 to $30.18 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. F6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.19 to $30.61 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. F7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.36 to $32.35 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. F8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.37 to $32.48 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Total shares sold: 100,000 shares Shares sold 2026-08-04 (tranche 1): 23,506 shares at $31.9217 per share Shares sold 2026-08-04 (tranche 2): 2,600 shares at $32.4149 per share +3 more

6 metrics

Total shares sold 100,000 shares Aggregate Arteris common stock sold by Bayview Legacy, LLC across five transactions

Shares sold 2026-08-04 (tranche 1) 23,506 shares at $31.9217 per share First reported indirect sale of common stock on August 4, 2026

Shares sold 2026-08-04 (tranche 2) 2,600 shares at $32.4149 per share Second reported indirect sale of common stock on August 4, 2026

Shares sold 2026-08-03 (tranche 1) 6,321 shares at $28.7865 per share Indirect sale of common stock on August 3, 2026 with weighted average pricing

Shares sold 2026-08-03 (tranche 2) 42,415 shares at $29.9906 per share Largest single reported tranche of indirect sales on August 3, 2026

Shares sold 2026-08-03 (tranche 3) 25,158 shares at $30.3132 per share Additional indirect sale of common stock on August 3, 2026

Key Terms

10b5-1 trading plan, weighted average sale price, beneficial ownership, voting and dispositive power

4 terms

10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted..."

A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price..."

beneficial ownership regulatory

"reporting the same transaction given his beneficial ownership of the reported security..."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

voting and dispositive power regulatory

"is deemed to have voting and dispositive power over the shares..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bayview Legacy, LLC report in its latest filing for Arteris (AIP)?

Bayview Legacy, LLC reported selling 100,000 shares of Arteris common stock in five indirect open‑market transactions on August 3–4, 2026. The sales were executed under a Rule 10b5‑1 trading plan adopted on December 12, 2025, by manager K. Charles Janac.

How were the Arteris (AIP) share sales by Bayview Legacy, LLC priced?

Each tranche’s reported price is a weighted average per share, including $28.7865, $29.9906, $30.3132, $31.9217 and $32.4149. Footnotes state the underlying trades occurred in ranges from $28.17 to $32.48 per share, with detailed breakdowns available on request.

Were Bayview Legacy’s Arteris (AIP) transactions direct or indirect holdings?

All reported sales involve indirect ownership. The filing lists Bayview Legacy’s common stock as indirect with “See Footnote,” explaining that manager K. Charles Janac is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

What is K. Charles Janac’s role in relation to Bayview Legacy and Arteris (AIP) shares?

K. Charles Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over its Arteris shares. A footnote states he has separately filed his own Form 4 reporting the same transactions due to his beneficial ownership through Bayview Legacy.

Were Bayview Legacy’s Arteris (AIP) sales made under a Rule 10b5‑1 trading plan?

Yes. A footnote states the transactions were made pursuant to a Rule 10b5‑1 trading plan adopted by K. Charles Janac, as manager of Bayview Legacy, LLC, on December 12, 2025. The filing’s Rule 10b5‑1 checkbox is also marked as affirming plan status.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 06:06 PM Accepted by SEC EDGAR 08/05/2026 - 06:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/03/2026		S(1)(2)		6,321	D	$28.7865(3)	8,422,750	I	See Footnote(4)
Common Stock	08/03/2026		S(1)(2)		42,415	D	$29.9906(5)	8,380,335	I	See Footnote
Common Stock	08/03/2026		S(1)(2)		25,158	D	$30.3132(6)	8,355,177	I	See Footnote
Common Stock	08/04/2026		S(1)(2)		23,506	D	$31.9217(7)	8,331,671	I	See Footnote
Common Stock	08/04/2026		S(1)(2)		2,600	D	$32.4149(8)	8,329,071	I	See Footnote

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.15 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.19 to $30.18 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.19 to $30.61 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.36 to $32.35 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.37 to $32.48 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ K. Charles Janac	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)